[go: up one dir, main page]

Moulder, 2001 - Google Patents

Mechanisms of neuronal death in in vitro and in vivo models of [CAG] trinucleotide repeat disease

Moulder, 2001

Document ID
87071592587699741
Author
Moulder K
Publication year

External Links

Snippet

The neuronal death that accompanies many neurodegenerative diseases is frequently described as apoptotic. However, this assessment is often made simply based on the observation of fragmented DNA. Therefore, we began studies on the mechanisms of toxicity …
Continue reading at search.proquest.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans

Similar Documents

Publication Publication Date Title
Thies et al. Missorting of tau in neurons causes degeneration of synapses that can be rescued by the kinase MARK2/Par-1
Carrettiero et al. The cochaperone BAG2 sweeps paired helical filament-insoluble tau from the microtubule
Kasher et al. Direct evidence for axonal transport defects in a novel mouse model of mutant spastin‐induced hereditary spastic paraplegia (HSP) and human HSP patients
Kasper et al. Loss of the chloride channel ClC‐7 leads to lysosomal storage disease and neurodegeneration
Liu et al. Accumulation of protein O‐GlcNAc modification inhibits proteasomes in the brain and coincides with neuronal apoptosis in brain areas with high O‐GlcNAc metabolism
Le et al. SMNΔ7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN
Chai et al. Analysis of the role of heat shock protein (Hsp) molecular chaperones in polyglutamine disease
Szebenyi et al. Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport
Yvert et al. Expanded polyglutamines induce neurodegeneration and trans-neuronal alterations in cerebellum and retina of SCA7 transgenic mice
Alexandru et al. Selective hippocampal neurodegeneration in transgenic mice expressing small amounts of truncated Aβ is induced by pyroglutamate–Aβ formation
King et al. Reduced levels of connexin43 in cervical dysplasia: inducible expression in a cervical carcinoma cell line decreases neoplastic potential with implications for tumor progression
Shepard et al. A renal olfactory receptor aids in kidney glucose handling
Burcklé et al. Control of the Wnt pathways by nephrocystin-4 is required for morphogenesis of the zebrafish pronephros
US9234038B2 (en) Compositions and method for the diagnosis, prevention and treatment of alzheimer's disease
US20020187931A1 (en) Modulating cell survival by modulating huntingtin function
Hickey et al. The use of transgenic and knock-in mice to study Huntington’s disease
Chowdhury et al. Apoptosis of rat granulosa cells after staurosporine and serum withdrawal is suppressed by adenovirus-directed overexpression of prohibitin
Haile et al. Granule-derived granzyme B mediates the vulnerability of human neurons to T cell-induced neurotoxicity
EP2605013A1 (en) Stimulation of pancreatic beta-cell proliferation
Bendiske et al. Intracellular deposition, microtubule destabilization, and transport failure: an “early” pathogenic cascade leading to synaptic decline
Schaefer et al. Progressive motor neuronopathy: a critical role of the tubulin chaperone TBCE in axonal tubulin routing from the Golgi apparatus
Kim et al. A pathogenic proteolysis–resistant huntingtin isoform induced by an antisense oligonucleotide maintains huntingtin function
US20070037202A1 (en) Potentiation of cancer therapies by ZNF217 inhibition
Kusakabe et al. Loss of cortical and thalamic neuronal tenascin‐C expression in a transgenic mouse expressing exon 1 of the human Huntington disease gene
Mhatre et al. Cloning and developmental expression of nonmuscle myosin IIA (Myh9) in the mammalian inner ear